Company Oncology Pharma Inc. Other OTC
Equities
ONPH
US68235J2015
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
George Malesek
CEO | Chief Executive Officer | - | - |
James B. Smith
DFI | Director of Finance/CFO | - | 21-01-27 |
Charles Wagner
CHM | Chairman | - | 14-09-29 |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stefan Gruenwald
BRD | Director/Board Member | - | 19-10-07 |
Charles Wagner
CHM | Chairman | - | 14-09-29 |
Carlos Barnett
BRD | Director/Board Member | - | - |
Shawn Crouse
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,563,216 | 38,563,216 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Oncology Pharma, Inc.
One Sansome Street Suite 3500
94104, San Francisco
+415-869-1036
![address Oncology Pharma Inc.(ONPH)](https://cdn.zonebourse.com/static/address/60037723.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+55.32% | 819B | |
-6.75% | 351B | |
+13.56% | 329B | |
+10.68% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.48% | 168B | |
-2.81% | 158B |